Oracle’s Q2 results reveal rising debt, heavy AI capex, and weakening fundamentals—signaling a potential cash crunch for the ...
Rocket Lab (RKLB) stock surged 10% today, closing at $63.53 per share, fueled by fresh reports that Elon Musk's SpaceX is ...
Boeing stock is rebounding in 2025 as the Spirit AeroSystems deal nears. With deliveries rising, is BA finally a buy—or still ...
MicroStrategy inspired Bitcoin treasuries—but Bitmine Immersion (BMNR) may be executing a smarter play. With $13B in Ethereum ...
Copper prices just hit record highs amid a global supply crunch. Learn why Freeport-McMoRan (FCX) is the top copper stock ...
Opendoor (OPEN) jumped 9% despite no news, but emerging housing-market tailwinds, falling mortgage rates, and renewed ...
SoFi’s $1.5B stock offering hits shares with dilution, sending SOFI down 7%. Here’s why the company raised capital, what it ...
Netflix’s $82.7B acquisition of Warner Bros and HBO Max expands its content empire, but adds huge debt and integration risks.
While Nvidia dominates AI headlines, Dollar General is quietly outperforming in 2025. Here’s why DG’s turnaround, value ...
The U.S. is funding xLight to advance next-gen EUV light sources, challenging ASML’s monopoly while boosting domestic ...
BeOne Medicines is up 75% in 2025 but off recent highs. China’s new private insurance drug list could unlock major growth for ONC in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results